Authors: L. Laho; P. Kenderessy Authors‘ workplace: Klinika pediatrickej anestézie a intenzívnej medicíny DFNsP, Banská Bystrica prednosta h. doc. MUDr. L. Laho, CSc. Published in: Čes-slov Pediat 2010; 65 (10): 571-574. Category: Original Papers
Analysis of the National Center of Public Health Information data (NCZI) oriented to incidence of hospitalized children with bronchiolitis in Slovakia in the period of 1996–2006 is presented. There were 790 children admitted to hospital. Among these, 569 children (72%) were up to the age of one year. The numbers of hospitalized children in individual years ranged from 45 (in 2001) to 112 (in 1996). The numbers of hospitalized sucklings were from 31 (1999) to 83 (2006), i.e. 0.6% or 1.5/1000. Four children died, three of them in their first year of life and one before the child reached two years of life. The suckling mortality for bronchiolitis was therefore 0.5/100,000 live born children. These numbers are several-fold lower than those reported from U.S.A. or Canada.
Conclusion: Incidence of bronchiolitis in children in Slovakia has been by order of magnitude less than those in the U.S.A. and Canada, respectively. In view of the close relationship between bronchiolitis and RSV the approach to prophylaxis of RSV should be reevaluated, since it was completely adopted from these two countries and the local risk of RSV re-hospitalization for the risk group of sucklings should be established.
Key words: bronchiolitis, incidence, RSV prophylaxis
1. The IMpact-RSV Study Group. Pelivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102(3): 531–537.
2. Langley JM, LeBlanc JC, Smith B, et al. Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980–2000. J. Infect. Dis. 2003; 188(11): 1764–1767.
3. Weigl JAI, Puppe W, Schmitt HJ. Incidence of respiratory syncytial virus-positive hopsitalizations in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 2001; 20(7): 452–459.
4. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999 Oct 20; 282(15): 1440–1446.
5. Dies DJ, Ridao LM, et al. Incicence and cost of hospitalizations for bronchiolitis and respiratory syncytial virus infections in the autonomous comunity of Valencia in Spain. An. Pediatr. (Barc.) 2006; 65(4): 325–330.
6. Kobr J, Pizingerová K, Honomichlová H, et al. Bronchiolitis acuta. Příspěvek k urychlení diagnózy a racionalizaci léčby. Čes.-slov. Pediat. 2001; 56(2): 62–73.
7. Henckel E, Luthander J, Berggren E, et al. Palivizumab prophylaxis and hospitalization for respiratory syncitial virus disease in the Stockholm infant population, 1999 through 2002. Pediatr. Infect. Dis. J. 2004; 23 : 27–31.
8. Liese JG, Grill E, Fischer B. Incidence and risk factors of respiratory syncitial virus-related hospitalizations in premature infants in Germany. Eur. J. Pediatr. 2003; 162(4): 230–236.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
